Scientists and researchers lack systems to reliably and accurately isolate individual cells from transfected or cultured cell suspensions or even heterogeneous samples such as whole blood. There is a growing need to study complex cell systems using next-gen approaches for rapidly emerging market segments including genetic engineering (e.g. CRISPR/Cas9), tumor heterogeneity, and drug discovery.
Current technologies for single-cell isolation suffer from a number of challenges including lack of cell viability, inefficiency of heterogeneous cell sample isolation, and high hands-on/training time. Furthermore, existing systems are typically restricted to core facilities due to price points and complexity of operation.